Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure

Cardiovascular Research

Volumn 51, Issue 3, 2001, Pages 608-617

  Maki, Toshiyuki ^a   Nasa, Yoshihisa ^a   Yamaguchi, Fuminari ^a   Yoshida, Hiroyuki ^a   Mori, Masaya ^a   Takada, Taku ^a   Horikawa, Eriko ^a   Okano, Kaori ^a   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Endothelins; Heart failure; Hemodynamics; Natriuretic peptide; Nitric oxide; Remodeling

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; ENKEPHALINASE INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; NEUROHORMONE; ONO 9902; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HEMODYNAMIC PARAMETERS; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; ATRIAL NATRIURETIC FACTOR; DRUG ADMINISTRATION SCHEDULE; ENDOTHELIN-1; ENKEPHALINS; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; MALE; NATRIURETIC PEPTIDE, BRAIN; NEPRILYSIN; RATS; RATS, WISTAR;

EID: 0035882212     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00258-9     Document Type: Article

References (26)

1. Peptide elevation in congestive heart failure in the human
2. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
3. Natriuretic peptides in the treatment of heart failure
4. Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure
5. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: Beneficial effects on left ventricular function
6. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
7. Characterization of neutral endopeptidase in vascular smooth muscle cells of rabbit renal cortex
8. Distribution of enkephalinase (membrane metalloendopeptidase, E.C. 3.4.24.11) in rat organs. Detection using a monoclonal antibody
9. Hydrolysis of α-human atrial natriuretic peptide in vitro by human kidney membranes and purified endopeptidase-24.11. Evidence for a novel cleavage site
10. Clearance mechanisms of atrial and brain natriuretic peptides in rats
11. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats
12. Clearance receptors and endopeptidase: Equal role in natriuretic peptide metabolism in heart failure
13. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure
14. Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure
15. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure
16. Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction
17. Antinociceptive effects of ONO-9902, an enkephalinase inhibitor, after visceral stress condition in rats
18. Regional energy metabolism of failing hearts following myocardial infarction
19. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure
20. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function
21. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
22. Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides
23. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: Quantitation by autoradiography
24. Comparison of the haemodynamic effects of adenosine monophosphate with sodium nitroprusside in a canine model of acute global left ventricular dysfunction
25. Long-term administration of atrial natriuretic peptide in patients with acute heart failure
26. The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides